Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

38 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer (De-ESCALaTE HPV): an open-label randomised controlled phase 3 trial.
Mehanna H, Robinson M, Hartley A, Kong A, Foran B, Fulton-Lieuw T, Dalby M, Mistry P, Sen M, O'Toole L, Al Booz H, Dyker K, Moleron R, Whitaker S, Brennan S, Cook A, Griffin M, Aynsley E, Rolles M, De Winton E, Chan A, Srinivasan D, Nixon I, Grumett J, Leemans CR, Buter J, Henderson J, Harrington K, McConkey C, Gray A, Dunn J; De-ESCALaTE HPV Trial Group. Mehanna H, et al. Among authors: dyker k. Lancet. 2019 Jan 5;393(10166):51-60. doi: 10.1016/S0140-6736(18)32752-1. Epub 2018 Nov 15. Lancet. 2019. PMID: 30449623 Free PMC article. Clinical Trial.
Altered fractionation in head and neck cancer.
Choudhury A, Dyker K, Sen M. Choudhury A, et al. Among authors: dyker k. Clin Oncol (R Coll Radiol). 2008 Apr;20(3):267. doi: 10.1016/j.clon.2007.12.009. Epub 2008 Jan 15. Clin Oncol (R Coll Radiol). 2008. PMID: 18226511 No abstract available.
Improving the therapeutic ratio in head and neck cancer.
Prestwich R, Dyker K, Sen M. Prestwich R, et al. Among authors: dyker k. Lancet Oncol. 2010 Jun;11(6):512-3. doi: 10.1016/S1470-2045(10)70060-7. Lancet Oncol. 2010. PMID: 20522378 No abstract available.
Feasibility and efficacy of induction docetaxel, cisplatin, and 5-fluorouracil chemotherapy combined with cisplatin concurrent chemoradiotherapy for nonmetastatic Stage IV head-and-neck squamous cell carcinomas.
Prestwich RJ, Öksüz DÇ, Dyker K, Coyle C, Şen M. Prestwich RJ, et al. Among authors: dyker k. Int J Radiat Oncol Biol Phys. 2011 Nov 15;81(4):e237-43. doi: 10.1016/j.ijrobp.2011.03.043. Epub 2011 May 27. Int J Radiat Oncol Biol Phys. 2011. PMID: 21620580
38 results